{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:14:10Z","timestamp":1793229250805,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-56703-2","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T06:08:20Z","timestamp":1743055700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["CD248-targeted BBIR-T cell therapy against late-activated fibroblasts in cardiac repair after myocardial infarction"],"prefix":"10.1038","volume":"16","author":[{"given":"Haiting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5196-5932","authenticated-orcid":false,"given":"Qi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningxin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6414-2273","authenticated-orcid":false,"given":"Qingbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9385-3242","authenticated-orcid":false,"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"56703_CR1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/jama.2022.0358","volume":"327","author":"DL Bhatt","year":"2022","unstructured":"Bhatt, D. L., Lopes, R. D. & Harrington, R. A. Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA 327, 662\u2013675 (2022).","journal-title":"JAMA"},{"key":"56703_CR2","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","volume":"43","author":"S Frantz","year":"2022","unstructured":"Frantz, S., Hundertmark, M. J., Schulz-Menger, J., Bengel, F. M. & Bauersachs, J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J 43, 2549\u20132561 (2022).","journal-title":"Eur Heart J"},{"key":"56703_CR3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","volume":"14","author":"MD Tallquist","year":"2017","unstructured":"Tallquist, M. D. & Molkentin, J. D. Redefining the identity of cardiac fibroblasts. Nat Rev Cardiol 14, 484\u2013491 (2017).","journal-title":"Nat Rev Cardiol"},{"key":"56703_CR4","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.celrep.2020.02.008","volume":"30","author":"E Forte","year":"2020","unstructured":"Forte, E. et al. Dynamic Interstitial Cell Response during Myocardial Infarction Predicts Resilience to Rupture in Genetically Diverse Mice. Cell Rep 30, 3149\u20133163 e3146 (2020).","journal-title":"Cell Rep"},{"key":"56703_CR5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.116.308643","volume":"118","author":"H Kaur","year":"2016","unstructured":"Kaur, H. et al. Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice. Circ Res 118, 1906\u20131917 (2016).","journal-title":"Circ Res"},{"key":"56703_CR6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian, H. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430\u2013433 (2019).","journal-title":"Nature"},{"key":"56703_CR7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.yjmcc.2015.08.016","volume":"87","author":"J Tillmanns","year":"2015","unstructured":"Tillmanns, J. et al. Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. J Mol Cell Cardiol 87, 194\u2013203 (2015).","journal-title":"J Mol Cell Cardiol"},{"key":"56703_CR8","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/0008-5472.CAN-11-3890","volume":"72","author":"K Urbanska","year":"2012","unstructured":"Urbanska, K. et al. A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor. Cancer Res 72, 1844\u20131852 (2012).","journal-title":"Cancer Res"},{"key":"56703_CR9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36, 411\u2013420 (2018).","journal-title":"Nat Biotechnol"},{"key":"56703_CR10","doi-asserted-by":"crossref","unstructured":"Farbehi, N. et al. Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury. Elife 8, e43882 (2019).","DOI":"10.7554\/eLife.43882"},{"key":"56703_CR11","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI98215","volume":"128","author":"X Fu","year":"2018","unstructured":"Fu, X. et al. Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. J Clin Investig 128, 2127\u20132143 (2018).","journal-title":"J Clin Investig"},{"key":"56703_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.matbio.2018.02.023","volume":"71-72","author":"KL Posey","year":"2018","unstructured":"Posey, K. L., Coustry, F. & Hecht, J. T. Cartilage oligomeric matrix protein: COMPopathies and beyond. Matrix Biol 71-72, 161\u2013173 (2018).","journal-title":"Matrix Biol"},{"key":"56703_CR13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109888","volume":"79","author":"IM Reichardt","year":"2021","unstructured":"Reichardt, I. M., Robeson, K. Z., Regnier, M. & Davis, J. Controlling cardiac fibrosis through fibroblast state space modulation. Cell Signal 79, 109888 (2021).","journal-title":"Cell Signal"},{"key":"56703_CR14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","volume":"127","author":"AA Gibb","year":"2020","unstructured":"Gibb, A. A., Lazaropoulos, M. P. & Elrod, J. W. Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation. Circ Res 127, 427\u2013447 (2020).","journal-title":"Circ Res"},{"key":"56703_CR15","doi-asserted-by":"crossref","unstructured":"Humeres, C. et al. Smad7 effects on TGF-beta and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure. J. Clin. Investig. 132, e146926 (2022).","DOI":"10.1172\/JCI146926"},{"key":"56703_CR16","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12260","volume":"7","author":"O Kanisicak","year":"2016","unstructured":"Kanisicak, O. et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun 7, 12260 (2016).","journal-title":"Nat Commun"},{"key":"56703_CR17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.RES.82.11.1130","volume":"82","author":"G Takemura","year":"1998","unstructured":"Takemura, G. et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 82, 1130\u20131138 (1998).","journal-title":"Circ Res"},{"key":"56703_CR18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 7, 78 (2022).","journal-title":"Signal Transduct Target Ther"},{"key":"56703_CR19","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/cphy.c150006","volume":"5","author":"NG Frangogiannis","year":"2015","unstructured":"Frangogiannis, N. G. Pathophysiology of Myocardial Infarction. Compr Physiol 5, 1841\u20131875 (2015).","journal-title":"Compr Physiol"},{"key":"56703_CR20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol 33, 495\u2013502 (2015).","journal-title":"Nat Biotechnol"},{"key":"56703_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"56703_CR22","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/ATVBAHA.122.317683","volume":"42","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. TMEM100, a Lung-Specific Endothelium Gene. Arterioscler Thromb Vasc Biol 42, 1495\u20131497 (2022).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"56703_CR23","first-page":"1488","volume":"20","author":"P Di Benedetto","year":"2019","unstructured":"Di Benedetto, P. et al. Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review). Mol Med Rep 20, 1488\u20131498 (2019).","journal-title":"Mol Med Rep"},{"key":"56703_CR24","doi-asserted-by":"crossref","first-page":"38795","DOI":"10.1074\/jbc.M105241200","volume":"276","author":"R Opavsky","year":"2001","unstructured":"Opavsky, R. et al. Molecular characterization of the mouse Tem1\/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo. J Biol Chem 276, 38795\u201338807 (2001).","journal-title":"J Biol Chem"},{"key":"56703_CR25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","volume":"377","author":"SC Jordan","year":"2017","unstructured":"Jordan, S. C. et al. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N. Engl J Med 377, 442\u2013453 (2017).","journal-title":"N. Engl J Med"},{"key":"56703_CR26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","volume":"20","author":"SA Dick","year":"2019","unstructured":"Dick, S. A. et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat Immunol 20, 29\u201339 (2019).","journal-title":"Nat Immunol"},{"key":"56703_CR27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107863","volume":"227","author":"K Kuwahara","year":"2021","unstructured":"Kuwahara, K. The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications. Pharmacol Ther 227, 107863 (2021).","journal-title":"Pharmacol Ther"},{"key":"56703_CR28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.annonc.2020.10.478","volume":"32","author":"ML Schubert","year":"2021","unstructured":"Schubert, M. L. et al. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy. Ann Oncol 32, 34\u201348 (2021).","journal-title":"Ann Oncol"},{"key":"56703_CR29","doi-asserted-by":"crossref","unstructured":"Thavapalachandran, S. et al. Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarction. Sci. Transl. Med. 12, eaay2140 (2020).","DOI":"10.1126\/scitranslmed.aay2140"},{"key":"56703_CR30","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/CIRCIMAGING.113.001293","volume":"7","author":"E Watanabe","year":"2014","unstructured":"Watanabe, E. et al. Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction. Circ Cardiovasc Imaging 7, 887\u2013894 (2014).","journal-title":"Circ Cardiovasc Imaging"},{"key":"56703_CR31","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1038\/s41586-019-1761-7","volume":"576","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian, H. et al. Author Correction: Targeting cardiac fibrosis with engineered T cells. Nature 576, E2 (2019).","journal-title":"Nature"},{"key":"56703_CR32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mvr.2008.07.008","volume":"76","author":"RG Bagley","year":"2008","unstructured":"Bagley, R. G. et al. Endosialin\/TEM 1\/CD248 is a pericyte marker of embryonic and tumor neovascularization. Microvasc Res 76, 180\u2013188 (2008).","journal-title":"Microvasc Res"},{"key":"56703_CR33","doi-asserted-by":"publisher","unstructured":"Li G., et al. Dynamic Molecular Atlas for Cardiac Fibrosis at Single-Cell and Spatial Resolution unveils CD248+ fibroblasts in Orchestrating Fibroblast-Immune Interaction. In press. Nat. Cardiovasc. Res. https:\/\/doi.org\/10.1038\/s44161-025-00617-1 (2025).","DOI":"10.1038\/s44161-025-00617-1"},{"key":"56703_CR34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","volume":"118","author":"AR Pinto","year":"2016","unstructured":"Pinto, A. R. et al. Revisiting Cardiac Cellular Composition. Circ Res 118, 400\u2013409 (2016).","journal-title":"Circ Res"},{"key":"56703_CR35","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.cell.2022.04.003","volume":"185","author":"A Chen","year":"2022","unstructured":"Chen, A. et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell 185, 1777\u20131792 e1721 (2022).","journal-title":"Cell"},{"key":"56703_CR36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56703-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56703-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56703-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T06:09:23Z","timestamp":1743055763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56703-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56703"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56703-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3551633\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"3 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2895"}}